Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of 161Tb-folate and 177Lu-folate

Renal function affects absorbed dose to the kidneys and haematological toxicity during 177Lu-DOTATATE treatment

(2015) Johanna Svensson et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Folate receptor-targeted radionuclide therapy: preclinical investigation of anti-tumor effects and potential radionephropathy

(2015) Stephanie Haller et al.   NUCLEAR MEDICINE AND BIOLOGY

Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

(2014) Jürgen Grünberg et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Direct in vitro and in vivo comparison of 161Tb and 177Lu using a tumour-targeting folate conjugate

(2013) Cristina Müller et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

177Lu-EC0800 Combined with the Antifolate Pemetrexed: Preclinical Pilot Study of Folate Receptor Targeted Radionuclide Tumor Therapy

(2013) Josefine Reber et al.   MOLECULAR CANCER THERAPEUTICS

Folate-Based Radiotracers for PET Imaging—Update and Perspectives

(2013) Cristina Müller   MOLECULES

Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation

(2012) Cristina Muller   CURRENT PHARMACEUTICAL DESIGN

A Unique Matched Quadruplet of Terbium Radioisotopes for PET and SPECT and for  - and  --Radionuclide Therapy: An In Vivo Proof-of-Concept Study with a New Receptor-Targeted Folate Derivative

(2012) C. Muller et al.   JOURNAL OF NUCLEAR MEDICINE

DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted 177Lu-Radionuclide Tumor Therapy in Mice

(2012) C. Muller et al.   JOURNAL OF NUCLEAR MEDICINE

A nephron-based model of the kidneys for macro-to-micro α-particle dosimetry

(2012) Robert F Hobbs et al.   PHYSICS IN MEDICINE AND BIOLOGY

The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy

(2011) Silvia Lehenberger et al.   NUCLEAR MEDICINE AND BIOLOGY

Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

(2010) E. Vegt et al.   JOURNAL OF NUCLEAR MEDICINE

Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury

(2010) Frank Dieterle et al.   NATURE BIOTECHNOLOGY

Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases

(2007) Philip S. Low et al.   ACCOUNTS OF CHEMICAL RESEARCH